Health authorities in Punjab have issued an important Allergy Medicine Warning after declaring a specific batch of Erizine 10 mg Tablets unfit for use. Officials urged the public to stop using the affected batch immediately and avoid purchasing it until further notice.
The Directorate of Drugs Control Punjab released the alert after receiving laboratory findings that raised serious concerns about the medicine’s quality. Authorities acted quickly to protect consumers from possible health risks.
The allergy medicine warning has become a major concern because Erizine 10 mg is one of the most commonly used medicines for seasonal allergies. Thousands of people rely on it to relieve sneezing, a runny nose, watery eyes, and itchy eyes during allergy season.
The Punjab Drug Testing Laboratory examined samples from the affected batch during routine quality testing. After completing the analysis, experts concluded that the batch failed to meet the required pharmaceutical standards.
Following the laboratory report, the Provincial Quality Control Board Punjab approved immediate regulatory action. Officials ordered the withdrawal of the affected batch from pharmacies and medical stores across the province.
Authorities instructed every pharmacy, medical store, hospital, and wholesale distributor in Punjab to stop selling the affected medicine without delay. They also directed businesses to separate the remaining stock from other medicines immediately.
Drug inspectors will now collect inventory details from pharmacies and distributors. This process will help authorities identify how much stock remains in the supply chain and where it is currently stored.
Officials also instructed the pharmaceutical company responsible for manufacturing and distributing the medicine to begin a nationwide recall. The company must recover the affected batch from every possible distribution point as quickly as possible.
The Allergy Medicine Warning also requires strict monitoring by drug enforcement teams throughout Punjab. Inspection teams will regularly visit pharmacies and healthcare facilities to ensure full compliance with the official orders.
Regulatory authorities announced that they will take legal action against anyone who continues to sell or distribute the affected batch. They will enforce these actions under the Drugs Act 1976 and the DRAP Act 2012.
Health officials emphasized that only the affected batch is covered by the current warning. Consumers should always verify the batch number before purchasing or using any medicine.
People who already purchased the affected tablets should stop taking them immediately. They should also consult a qualified healthcare professional if they experience any unusual symptoms after using the medicine.
The Allergy Medicine Warning highlights the importance of quality control in Pakistan’s pharmaceutical industry. Regular laboratory testing plays a critical role in identifying medicines that fail to meet approved safety standards.
Experts encourage consumers to purchase medicines only from licensed pharmacies. Buying medicines from trusted sources reduces the risk of receiving counterfeit, expired, or substandard products.
Patients should never ignore official drug safety alerts. Government health agencies release these notices to prevent serious health complications and protect public safety.
Doctors also recommend checking medicine packaging carefully before use. Consumers should confirm the product name, expiry date, manufacturer, and batch number every time they purchase prescription or over-the-counter medicines.
Healthcare professionals believe public awareness can significantly improve medicine safety. People who understand official warnings often respond quickly and avoid unnecessary health risks.
Officials continue to monitor the recall process closely across Punjab. They expect pharmacies and distributors to cooperate fully with the inspection teams during the recovery operation.
The provincial government also plans to verify that all affected stock returns to the manufacturer. This step will help prevent the medicine from reaching consumers through unauthorized channels.
The Allergy Medicine Warning serves as a reminder that medicine quality remains a top public health priority. Regulatory agencies continue to strengthen inspection systems and improve market surveillance to protect patients across Pakistan.
Authorities have advised citizens to stay informed through official health announcements rather than relying on social media rumors. Anyone who possesses the affected batch should stop using it immediately and seek guidance from a pharmacist or healthcare provider if necessary.
Officials believe the swift recall will reduce potential health risks and strengthen public confidence in Pakistan’s medicine safety system. They also reaffirmed their commitment to ensuring that only safe and high-quality medicines remain available in the market.
